scFv-based biologics in diabetes: from therapeutic potential to clinical prospects - Top-Institutions - MDSpire

scFv-based biologics in diabetes: from therapeutic potential to clinical prospects

  • By

  • Shikun Ge

  • Luoxuan Wang

  • Yichen Huang

  • Huaizu Guo

  • Fuyao Wei

  • Pan Li

  • Siyuan Li

  • Qian Liu

  • Jin Xu

  • Yilei Xiao

  • Alberto Carlos Piress Dias

  • Lusha Ji

  • June 4, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Arena Eye Surgeons
    Arena Eye Surgeons

    Burlington, MA

    Key Differentiators

    • Ophthalmology

  • #2

    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Diabetes and Digestive and Kidney Diseases

    Bethesda, MD

    Key Differentiators

    • Diabetes
    • Digestive Diseases
    • Kidney Diseases

  • #3

    Mass Eye and Ear
    Mass Eye and Ear

    Boston, MA

    Key Differentiators

    • Ophthalmology

  • #4

    Johns Hopkins Kimmel Cancer Center
    Johns Hopkins Kimmel Cancer Center

    Baltimore, MD

    Key Differentiators

    • Oncology

  • #5

    Rutgers University
    Rutgers University

    New Brunswick, NJ

    Key Differentiators

    • Biotechnology
    • Medicine

Original Source(s)

scFv-based biologics in diabetes: from therapeutic potential to clinical prospects

  • by Shikun Ge, Luoxuan Wang, Yichen Huang, Huaizu Guo, Fuyao Wei, Pan Li, Siyuan Li, Qian Liu, Jin Xu, Yilei Xiao, Alberto Carlos Piress Dias, Lusha Ji

  • June 4, 2026

Related Content

Detection of Referable Diabetic Retinopathy using Machine Learning on Routine Clinical Data

Correlation of Triglyceride-Glucose Index with Diabetic Retinopathy in Diabetic Patients in Nepal: A Cross-Sectional Analysis

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."